NEW YORK (GenomeWeb News) – Dementia diagnostics firm Cytox today said that it raised £1.5 million ($2.5 million) in a second round of funding.

The financing was led by existing investor Spark Impact, manager of The North West Fund for Biomedical. Other existing investors, including Wren Capital, the Rainbow Seed Fund, and private investors also participated in the round, as did new investor Seneca Partners.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.